Clinical Evaluation of Ultrashort-term Heat Inactivation of Cytomegalovirus (CMV) Containing Raw Breast Milk to Prevent CMV-infection of Preterm Infants
NCT ID: NCT01178905
Last Updated: 2013-04-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
INTERVENTIONAL
2010-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The protocol has been approved by the ethics committee of Tuebingen University Hospital.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cytomegalovirus (CMV) Transmission by Frozen Breast Milk in Preterms
NCT00668798
Transfusion-Transmitted Cytomegalovirus Prevention in Neonates
NCT00000584
Prenatal Behavioral Intervention to Prevent Maternal Cytomegalovirus (CMV) in Pregnancy
NCT04615715
Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus
NCT01251744
Epidemiology of Human Cytomegalovirus Excretion in the Saliva of Children Attending Nursery in France
NCT01704222
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mother CMV positive
ultrashort heat inactivation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrashort heat inactivation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* mother CMV IgG positive
* breast milk feeding
Exclusion Criteria
23 Weeks
40 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Tuebingen
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rangamr Goelz, MD
Role: PRINCIPAL_INVESTIGATOR
Tuebingen University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tuebingen University Hospital
Tübingen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bapistella S, Hamprecht K, Thomas W, Speer CP, Dietz K, Maschmann J, Poets CF, Goelz R. Short-term Pasteurization of Breast Milk to Prevent Postnatal Cytomegalovirus Transmission in Very Preterm Infants. Clin Infect Dis. 2019 Jul 18;69(3):438-444. doi: 10.1093/cid/ciy945.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BM CMV inactivation
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.